Key result
The right gastroepiploic artery can be used as a coronary artery bypass graft with an in-hospital mortality of 1.6% and a mid-term angiographic patency rate of 91.8%.
Why the study?
Does the use of the right gastroepiploic artery as a coronary artery bypass graft provide acceptable safety and patency in patients undergoing coronary surgery?
Population
307 patients undergoing coronary artery bypass surgery, average age 56.5 years, 89% male. Included 8.5%…
Design
Case_series
Follow-up
average 26 months (range 6-88)
Authors
Loading...
May support right gastroepiploic artery as CABG conduit in select patients; leaves open need for randomized confirmation.
Observational (n=307)
Does the use of the right gastroepiploic artery as a coronary artery bypass graft provide acceptable safety and patency in patients undergoing coronary surgery?
The right gastroepiploic artery is a viable conduit for coronary artery bypass surgery, demonstrating low mortality and high mid-term patency.
Albertini et al. (1998) conducted an observational in Coronary artery disease requiring bypass surgery (n=307). Right gastroepiploic artery graft was evaluated on Patency of the right gastroepiploic artery grafts. The right gastroepiploic artery can be used as a coronary artery bypass graft with an in-hospital mortality of 1.6% and a mid-term angiographic patency rate of 91.8%.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: